FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3020565800> ?p ?o ?g. }

• W3020565800 endingPage "19" @default.
• W3020565800 startingPage "12" @default.
• W3020565800 abstract "Abstract Anticoagulant plasma concentrations and patient characteristics might affect the benefit–risk balance of therapy. The study objective was to assess the impact of model-predicted rivaroxaban exposure and patient characteristics on outcomes in patients receiving rivaroxaban for venous thromboembolism (VTE) prophylaxis (VTE-P) after hip/knee replacement surgery. Post hoc exposure–response analyses were conducted using data from the phase 3 RECORD1–4 studies, in which 12,729 patients were randomized to rivaroxaban 10 mg once daily or enoxaparin for ≤ 39 days. Multivariate regression approaches were used to correlate model-predicted individual rivaroxaban exposures and patient characteristics with outcomes. In the absence of measured rivaroxaban exposure, exposure estimates were predicted based on individual increases in prothrombin time (PT) and by making use of the known correlation between rivaroxaban plasma concentration and dynamics of PT. No significant associations between rivaroxaban exposure and total VTE or major bleeding were identified. A significant association between exposure and a composite of major or non-major clinically relevant (NMCR) bleeding from day 4 after surgery was observed. The relationship was shallow, with an approximate predicted absolute increase in a composite of major or NMCR bleeding from 1.08 [95% confidence interval (CI) 0.76–1.54] to 2.18% (95% CI 1.51–3.17) at the 5th and 95th percentiles of trough plasma concentration, respectively. In conclusion, based on the underlying data and analysis, no reliable target window for exposure with improved benefit–risk could be identified within the investigated exposure range. Hence, monitoring rivaroxaban levels is unlikely to be beneficial in VTE-P." @default.
• W3020565800 created "2020-05-01" @default.
• W3020565800 creator A5009158219 @default.
• W3020565800 creator A5023161395 @default.
• W3020565800 creator A5034038133 @default.
• W3020565800 creator A5042548034 @default.
• W3020565800 creator A5044550530 @default.
• W3020565800 creator A5046676204 @default.
• W3020565800 creator A5055052720 @default.
• W3020565800 creator A5062673118 @default.
• W3020565800 creator A5067028141 @default.
• W3020565800 creator A5082464840 @default.
• W3020565800 creator A5088101863 @default.
• W3020565800 creator A5088267718 @default.
• W3020565800 date "2020-04-23" @default.
• W3020565800 modified "2023-09-23" @default.
• W3020565800 title "Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism" @default.
• W3020565800 cites W1808477918 @default.
• W3020565800 cites W1847159932 @default.
• W3020565800 cites W1971031736 @default.
• W3020565800 cites W1976934051 @default.
• W3020565800 cites W1989930316 @default.
• W3020565800 cites W2002831535 @default.
• W3020565800 cites W2008333987 @default.
• W3020565800 cites W2014491911 @default.
• W3020565800 cites W2017582897 @default.
• W3020565800 cites W2036506340 @default.
• W3020565800 cites W2052938071 @default.
• W3020565800 cites W2057065644 @default.
• W3020565800 cites W2059928999 @default.
• W3020565800 cites W2066676409 @default.
• W3020565800 cites W2068476516 @default.
• W3020565800 cites W2101613834 @default.
• W3020565800 cites W2111139930 @default.
• W3020565800 cites W2115019673 @default.
• W3020565800 cites W2115513773 @default.
• W3020565800 cites W2135583595 @default.
• W3020565800 cites W2150567120 @default.
• W3020565800 cites W2151252098 @default.
• W3020565800 cites W2168403443 @default.
• W3020565800 cites W2328645054 @default.
• W3020565800 cites W2435423552 @default.
• W3020565800 cites W2621458033 @default.
• W3020565800 cites W2761338333 @default.
• W3020565800 cites W2800220890 @default.
• W3020565800 cites W2955314196 @default.
• W3020565800 cites W3125937743 @default.
• W3020565800 doi "https://doi.org/10.1007/s11239-020-02078-8" @default.
• W3020565800 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7293979" @default.
• W3020565800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32323191" @default.
• W3020565800 hasPublicationYear "2020" @default.
• W3020565800 type Work @default.
• W3020565800 sameAs 3020565800 @default.
• W3020565800 citedByCount "4" @default.
• W3020565800 countsByYear W30205658002021 @default.
• W3020565800 countsByYear W30205658002022 @default.
• W3020565800 countsByYear W30205658002023 @default.
• W3020565800 crossrefType "journal-article" @default.
• W3020565800 hasAuthorship W3020565800A5009158219 @default.
• W3020565800 hasAuthorship W3020565800A5023161395 @default.
• W3020565800 hasAuthorship W3020565800A5034038133 @default.
• W3020565800 hasAuthorship W3020565800A5042548034 @default.
• W3020565800 hasAuthorship W3020565800A5044550530 @default.
• W3020565800 hasAuthorship W3020565800A5046676204 @default.
• W3020565800 hasAuthorship W3020565800A5055052720 @default.
• W3020565800 hasAuthorship W3020565800A5062673118 @default.
• W3020565800 hasAuthorship W3020565800A5067028141 @default.
• W3020565800 hasAuthorship W3020565800A5082464840 @default.
• W3020565800 hasAuthorship W3020565800A5088101863 @default.
• W3020565800 hasAuthorship W3020565800A5088267718 @default.
• W3020565800 hasBestOaLocation W30205658001 @default.
• W3020565800 hasConcept C126322002 @default.
• W3020565800 hasConcept C2776301958 @default.
• W3020565800 hasConcept C2778205648 @default.
• W3020565800 hasConcept C2778661090 @default.
• W3020565800 hasConcept C2779161974 @default.
• W3020565800 hasConcept C2780868729 @default.
• W3020565800 hasConcept C2991741193 @default.
• W3020565800 hasConcept C42219234 @default.
• W3020565800 hasConcept C44249647 @default.
• W3020565800 hasConcept C71924100 @default.
• W3020565800 hasConceptScore W3020565800C126322002 @default.
• W3020565800 hasConceptScore W3020565800C2776301958 @default.
• W3020565800 hasConceptScore W3020565800C2778205648 @default.
• W3020565800 hasConceptScore W3020565800C2778661090 @default.
• W3020565800 hasConceptScore W3020565800C2779161974 @default.
• W3020565800 hasConceptScore W3020565800C2780868729 @default.
• W3020565800 hasConceptScore W3020565800C2991741193 @default.
• W3020565800 hasConceptScore W3020565800C42219234 @default.
• W3020565800 hasConceptScore W3020565800C44249647 @default.
• W3020565800 hasConceptScore W3020565800C71924100 @default.
• W3020565800 hasIssue "1" @default.
• W3020565800 hasLocation W30205658001 @default.
• W3020565800 hasLocation W30205658002 @default.
• W3020565800 hasLocation W30205658003 @default.
• W3020565800 hasOpenAccess W3020565800 @default.
• W3020565800 hasPrimaryLocation W30205658001 @default.
• W3020565800 hasRelatedWork W1866105834 @default.

• next